Historical review of melanoma treatment and outcomes

被引:71
作者
Lee, Carrie [1 ]
Collichio, Frances
Ollila, David
Moschos, Stergios
机构
[1] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA
关键词
CUTANEOUS MALIGNANT-MELANOMA; LYMPH-NODE DISSECTION; METASTATIC MELANOMA; RECOMBINANT INTERLEUKIN-2; IMIDAZOLE CARBOXAMIDE; IMMUNOLOGICAL FACTORS; VIRUS INTERFERENCE; PROGNOSTIC-FACTORS; CANCER REGRESSION; STAGE-1; MELANOMA;
D O I
10.1016/j.clindermatol.2012.08.015
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The surgical and medical management of melanoma has changed dramatically since the first description of melanoma as a disease entity more than 200 years ago. Refinement of surgical techniques, including evaluation of optimal surgical margins, utility of elective lymph node dissection, and incorporation of sentinel lymph node mapping as both a prognostic tool and guide for selective lymphadenectomy have lessened surgical morbidity and improved outcomes for early-stage and locally advanced melanoma. Astute clinical observations of the integrated roles of the immune system and oncogenic mutations have more recently led to improvements in survival and quality of life for advanced melanoma. Herein, we provide an overview of the most significant surgical and medical milestones in the treatment of melanoma over the past 2 centuries. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 71 条
[1]   Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma [J].
Agarwala, SS ;
Glaspy, J ;
O'Day, SJ ;
Mitchell, M ;
Gutheil, J ;
Whitman, E ;
Gonzalez, R ;
Hersh, E ;
Feun, L ;
Belt, R ;
Meyskens, F ;
Hellstrand, K ;
Wood, D ;
Kirkwood, JM ;
Gehlsen, KR ;
Naredi, P .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :125-133
[2]  
American Joint Committee on Cancer, 1992, MAN STAG CANC, P143
[3]  
[Anonymous], 1909, Ned. Tijdschr. Geneeskd.
[4]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[5]   Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger [J].
Balch, CM ;
Soong, SJ ;
Bartolucci, AA ;
Urist, MM ;
Karakousis, CP ;
Smith, TJ ;
Temple, WJ ;
Ross, MI ;
Jewell, WR ;
Mihm, MC ;
Barnhill, RL ;
Wanebo, HJ .
ANNALS OF SURGERY, 1996, 224 (03) :255-263
[6]   EFFICACY OF 2-CM SURGICAL MARGINS FOR INTERMEDIATE-THICKNESS MELANOMAS (1 TO 4 MM) - RESULTS OF A MULTIINSTITUTIONAL RANDOMIZED SURGICAL TRIAL [J].
BALCH, CM ;
URIST, MM ;
KARAKOUSIS, CP ;
SMITH, TJ ;
TEMPLE, WJ ;
DRZEWIECKI, K ;
JEWELL, WR ;
BARTOLUCCI, AA ;
MIHM, MC ;
BARNHILL, R ;
WANEBO, HJ .
ANNALS OF SURGERY, 1993, 218 (03) :262-269
[7]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[8]  
BALCH CM, 1993, ANN SURG, V217, P207
[9]   Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The oblimersen melanoma study group [J].
Bedikian, Agop Y. ;
Millward, Michael ;
Pehamberger, Hubert ;
Conry, Robert ;
Gore, Martin ;
Trefzer, Uwe ;
Pavlick, Anna C. ;
DeConti, Ronald ;
Hersh, Evan M. ;
Hersey, Peter ;
Kirkwood, John M. ;
Haluska, Frank G. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) :4738-4745
[10]   QUANTITATIVE STUDIES ON TISSUE TRANSPLANTATION IMMUNITY .3. ACTIVELY ACQUIRED TOLERANCE [J].
BILLINGHAM, RE ;
BRENT, L ;
MEDAWAR, PB .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1956, 239 (666) :357-412